Overview
Status
Active
Registry date
2022-05-19
Share capital
5,050.00 PLN
Financials
Only balance sheet data (assets and liabilities) is available. The income statement (P&L) is not available in the source filing for this period.
Revenue history
Filing timeliness
4 of 4 financial statements were filed late (the longest delay 898 days for 2022).
- 202516/07/2026
- 202429/12/2025
- 202329/12/2025
- 202229/12/2025
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Authorized Representatives
Mateusz Krzysztof Kawka – President of the Management Board
Manner of representation
In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Zuzanna Czarnomskaage 27 | 25 | $337.66 | 24.7525% |
Paweł Jan Góraage 35 | 25 | $337.66 | 24.7525% |
Mateusz Krzysztof Kawkaage 34 | 26 | $351.16 | 25.7426% |
Michał Markowskiage 27 | 25 | $337.66 | 24.7525% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| FamicordtxS.A. | $1,365,068.41 | famicordtx.com | ||
| Medicofarma BiotechS.A. | $314,882.33 | medicofarmabiotech.pl | ||
| Explorna Therapeuticssp. z o.o. | $304,662.00 | explorna.com | ||
| Frontline BiosciencesS.A. | $219,186.29 | frontlinebiosciences.com | ||
| AI Corelabsp. z o.o. | $128,365.55 | aicorelab.com | ||
| ModicaP.S.A. | $103,400.72 | modica.bio | ||
| Bioselsp. z o.o. | $19,100.32 | selol.pl | ||
| Omnisepticasp. z o.o. | $3,475.29 | omniseptica.com | ||
| LASTsp. z o.o. | – | last-skincare.com | ||
| Nawah Scientific Polandsp. z o.o. | – | nawah-scientific.com |
FAQ
The main business activity of Genetactics focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on May 19, 2022.
The headquarters is located at: ul. Głębocka 88, 03-287 Warszawa.
The management board consists of: Mateusz Krzysztof Kawka (President of the Management Board).
The share capital of the company is PLN 5,050 (approx. $1,364).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
Last updated: 2026-07-16